Pharmafile Logo
Pharmafocus logo
Advanced Search
teva image

Teva plans sale of troubled Irvine plant

February 11, 2013
Manufacturing and Production FDA, Teva

Teva has decided to sell off an injectable pharmaceutical production plant in Irvine, California, that was shut down temporarily for …

News
screen_shot_2013-02-11_at_11

Teva appoints Arie Belldegrun to Board of directors

February 11, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Arie Belldegrun, Teva

Teva Pharmaceuticals has announced that Dr Arie Belldegrun has been appointed by the directors of Teva to fill a vacancy …

Appointment

£20m research boost for Scottish biotech

February 11, 2013
Research and Development, Sales and Marketing Bayer, BioCity Scotland, Dundee, EFPIA

BioCity Scotland and the University of Dundee are to play key roles in a newly-launched pan-European drug discovery project. In …

News
novartis image

Novartis’ Nebraska OTC plant still troubles company

February 11, 2013
Manufacturing and Production Novartis, OTC

Novartis has been forced to recall various over-the-counter (OTC) medicines made at its plant in Lincoln, Nebraska, after discovering failures …

News

Contract research news in brief

February 11, 2013
Research and Development Antabio, Aptuit, Argenta, Cross Country Healthcare, ICON, PPD, Quintiles, Verum.de

Icon offers $52m for CCH’s clinical services division, plus updates from PPD, Aptuit, Argenta, Quintiles and Verum.de.

News

Pharma manufacturing news in brief

February 11, 2013
Manufacturing and Production Almac, MeadWestvaco, Rexam, UPS, lilly

A round-up of pharma manufacturing news, including facility updates from MeadWestvaco, Rexam, Almac, UPS and Kemwell Biopharma. MeadWestvaco has said …

News

Sanofi won’t follow trend for spin-offs

February 8, 2013
Sales and Marketing Abbott, Pfizer, Sanofi, Viehbacher

Sanofi’s chief executive Chris Viehbacher says the firm plans to maintain its portfolio of business divisions for the foreseeable future, …

News
GSK image

‘Challenging’ Europe slows GSK

February 8, 2013
Sales and Marketing GSK, austerity, restructuring

‘Challenging’ economic conditions in Europe are among the factors GlaxoSmithKline is blaming for its sluggish performance, with turnover worldwide down …

News
lilly image

Lilly abandons RA drug

February 8, 2013
Research and Development, Sales and Marketing RA, lilly, tabalumab

Lilly is abandoning its late-stage trial into investigational rheumatoid arthritis (RA) drug tabalumab but insists the move has nothing to …

News

Lexapro US loss hits Lundbeck

February 7, 2013
Sales and Marketing Danish, Lexapro, Lundbeck

The loss of US patent protection on antidepressant Lexapro has put a significant dent in Lundbeck’s financial performance for 2012. …

News
image

Market access: please, no more talk of ‘hurdles’ and ‘obstacles’

February 7, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing barr, market access, pm society

For the UK pharmaceutical industry, biotech or devices firms, any discussion around market access tends to be synonymous with ‘hurdles’ …

Feature
curt-doty

Weber Shandwick makes several appointments

February 7, 2013
Medical Communications, Sales and Marketing Weber shandwick

PR firm Weber Shandwick has announced a series of new hires to strengthen its leadership across the strategy, creative, media …

Appointment
mid staffs image

‘Sad and shameful day’ for NHS

February 7, 2013
Sales and Marketing Cameron, GMC, Mid Staffs, NHS

The Department of Health has pledged its commitment “to a renewed focus on putting patients at the centre of everything …

News

Bayer/Janssen seek Xa inhibitor antidote

February 6, 2013
Research and Development, Sales and Marketing Bayer, Janssen, PRT4445, Xarelto

Bayer HealthCare and Janssen Pharmaceuticals have signed a deal with Portola Pharmaceuticals to evaluate the safety of an investigational antidote …

News
GSK image

GSK announces AllTrials support

February 6, 2013
Research and Development, Sales and Marketing ABPI, Bad pharma, GSK, Goldacre

GlaxoSmithKline has this morning found itself in the unusual position of being showered with praise by one of its fiercest …

News
screen_shot_2013-02-05_at_14

Aesica recruits operations director

February 5, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Aesica, CMO

Contract manufacturing organisation (CMO) Aesica has appointed Jarrett Palmer as Operations director of its formulated products business unit business. Palmer …

Appointment

Sanofi celebrates EU approvals

February 5, 2013
Sales and Marketing Lyxumia, Sanofi, Zaltrap, diabetes

Sanofi is celebrating after diabetes treatment Lyxumia (lixisenatide) and metastatic colorectal cancer (mCRC) drug Zaltrap received authorisation in Europe. The …

News
lennernas_2

Recipharm appoints Hans Lennernäs to operating Board

February 5, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Recipharm

Recipharm Pharmaceutical Development AB has announced the appointment of Dr Hans Lennernäs to the company’s Board of directors. Lennernäs is …

Appointment
ABPI image

GP concern over GMC guidance

February 5, 2013
Sales and Marketing ABPI, GMC, GP, NHS

The ABPI has ‘warmly’ welcomed the new prescribing guidance from the General Medical Council – but GPs are far from …

News
Shanghai image

SFDA publishes high-risk excipients list

February 5, 2013
Manufacturing and Production China, GMP, SFDA

China’s State Food and Drug Administration (SFDA) has published a list of 28 excipients which are considered high-risk and therefore …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026